A simplified system that modulates these functions could pave the way toward scalable, consistent CD4+ T cell or “helped” CD8+ T cell cancer therapies, while also providing mechanistic insight into CD4+ T cell tumor biology. This evidence concerns the gene CD4 and neoplasm.